Concepedia

Charles J. Rotter

CJ

Statistics

Publications

20

Citations

1.8K

H-Index

19

Active since

2009

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

The University of Queensland

Bristol-Myers Squibb (United Kingdom)

Novartis (United States)

Charles J. Rotter is an author at Pfizer (United States) specializing in pharmacy, pharmacology, and drug disposition.

Publications per year

2009–2016

20

Publications

20

Physicochemical Space for Optimum Oral Bioavailability: Contribution of Human Intestinal Absorption and First-Pass Elimination

Manthena V. S. Varma, R. Scott Obach, Charles J. Rotter et al. · Journal of Medicinal Chemistry · 2010 · 325 citations

, , +16

Development of a new permeability assay using low‐efflux MDCKII cells

Li Di, Carrie Whitney‐Pickett, John P. Umland et al. · Journal of Pharmaceutical Sciences · 2011 · 317 citations

, , +10

pH-Dependent Solubility and Permeability Criteria for Provisional Biopharmaceutics Classification (BCS and BDDCS) in Early Drug Discovery

Manthena V. S. Varma, Iain Gardner, Stefanus J. Steyn et al. · Molecular Pharmaceutics · 2012 · 164 citations

, , +17

Improving on Nature: Making a Cyclic Heptapeptide Orally Bioavailable

Daniel S. Nielsen, Huy N. Hoang, Rink‐Jan Lohman et al. · Angewandte Chemie International Edition · 2014 · 140 citations

, , +17

Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance

Arthur C Rand, Siegfried S. F. Leung, Heather Eng et al. · MedChemComm · 2012 · 131 citations

, , +17

1–5 of 20